Franklin by QIAGEN logo — Franklin harnesses the power of its community to enable acti...

Franklin by QIAGEN

Franklin harnesses the power of its community to enable actionable insights, serving professionals at the point of care

Founded 2014 United States Palo Alto, United States 53 employees Acquired Total: $101.50M AI, Biotechnology +4

General Information

Company Name Franklin by QIAGEN
Founded Year 2014
Location United States Palo Alto, United States
Employees 53
Industries AI, Biotechnology, Cloud Infrastructure +3
Funding Stage Acquired
Business Model B2B, SaaS, Platform
Revenue Model Subscription, Tiered Pricing, Usage Based
Social

BounceWatch is an independent company data service, not affiliated with Franklin by QIAGEN. To contact Franklin by QIAGEN, visit genoox.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Franklin by QIAGEN

GENOOX, founded in 2014, is a pioneering company in the intersection of AI, Cloud Infrastructure, and Health Care. Known for its slogan, "Genoox harnesses the power of its community to enable actionable insights, serving professionals at the point of care," the company is making a significant impact in the genomic data space.

The company's standout platform, Franklin, builds on a cloud-based AI infrastructure to connect clinicians, genetic counselors, and healthcare organizations. It is utilized by over 1,700 health organizations across 44 markets globally, providing users with advanced genomic tools and the ability to make impactful discoveries at the point of care.

Headquartered in the United States, GENOOX most recently secured an $8.00M Series B investment on 01 February 2021, backed by investors like TriVentures, Glilot Capital, Inimiti, IN Venture, and Infinity Medical. This robust support underscores its potential in transforming healthcare delivery.

Taxonomy: Genomic analysis, Bioinformatics, Precision Medicine, Clinical Trial Matching, Variant assessment, Rare Disease analysis, Prenatal examination, Oncology and tumor profiling, Pharmacogenomics, Genetic Testing, Real-world evidence network, Cloud-based AI platform, Community-driven insights, Healthcare organizations, Global market presence

Services & Products

Genomic data interpretation
Genetic variant analysis
Knowledge base for genomic information
Case management for genomic data

Target Customers

Healthcare professionals Genetic counselors Research scientists Clinical laboratories

Funding Rounds & Investors (9)

View All
Funding Stage Amount Investors Lead Investors Date
Acquisition $70.00M 1
Qiagen
01 May 2025
Series C $12.00M -
01 Aug 2023
Series B $8.00M 5
TriVentures, Glilot Capital +3
01 Feb 2021
Early VC $6.00M 3
TriVentures, Inimiti +1
01 May 2018
Series A €5.50M 2
Glilot Capital, Inimiti
01 Jul 2017
Grant Undisclosed 1
MassChallenge
01 Nov 2016
Grant Undisclosed 1
Microsoft for Startups
01 Mar 2016
Support Program Undisclosed 1
Google for Startups Accelerator
01 Dec 2014
Seed Undisclosed 1
UpWest Labs
01 Aug 2014

Franklin by QIAGEN Alternatives & Competitors

View All Alternatives
Franklin by QIAGEN vs

Personalized Genomics For A Healthier Future

Private Equity
637 employees
Biotechnology, Health Care
Franklin by QIAGEN vs
Fabric Genomics
Fabric Genomics United States

AI‑Driven Clinical Insights for Genomic Data

Venture round
27 employees
AI, Biotechnology
Franklin by QIAGEN vs
FullDNA
FullDNA Germany

Preventing Illness before it happens translates into better care

6 employees
Analytics, Biotechnology

FAQ About Franklin by QIAGEN

Franklin harnesses the power of its community to enable actionable insights, serving professionals at the point of care
Franklin by QIAGEN was founded in 2014.
Franklin by QIAGEN is headquartered in Palo Alto, United States.
Franklin by QIAGEN operates in AI, Biotechnology, Cloud Infrastructure, Health Care, Health and Wellness and Machine Learning. Its work centres on Genomic analysis, Bioinformatics, Precision Medicine and Clinical Trial Matching. Its customers include Healthcare professionals, Genetic counselors and Research scientists.
Franklin by QIAGEN has a B2B, SaaS and Platform business model. Its revenue comes from Subscription, Tiered Pricing and Usage Based.
Franklin by QIAGEN has approximately 53 employees.
Franklin by QIAGEN has completed 9 funding rounds, raising a total of $101.50M. The latest funding stage is Acquired.
Franklin by QIAGEN offers: Genomic data interpretation, Genetic variant analysis, Knowledge base for genomic information, Case management for genomic data.
Top alternatives and competitors to Franklin by QIAGEN include Strand Life Sciences, Fabric Genomics, FullDNA, Dhiti Omics, Massive Bio. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Franklin by QIAGEN and Strand Life Sciences are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Franklin by QIAGEN, https://bouncewatch.com/company/genoox, updated 21 July 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes